• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辣椒平作为系统x和癌症诱导骨痛新型抑制剂的鉴定。

Identification of capsazepine as a novel inhibitor of system x and cancer-induced bone pain.

作者信息

Fazzari Jennifer, Balenko Matthew D, Zacal Natalie, Singh Gurmit

机构信息

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

出版信息

J Pain Res. 2017 Apr 18;10:915-925. doi: 10.2147/JPR.S125045. eCollection 2017.

DOI:10.2147/JPR.S125045
PMID:28458574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5402992/
Abstract

The cystine/glutamate antiporter has been implicated in a variety of cancers as a major mediator of redox homeostasis. The excess glutamate secreted by this transporter in aggressive cancer cells has been associated with cancer-induced bone pain (CIBP) from distal breast cancer metastases. High-throughput screening of small molecule inhibitors of glutamate release from breast cancer cells identified several potential compounds. One such compound, capsazepine (CPZ), was confirmed to inhibit the functional unit of system x (xCT) through its ability to block uptake of its radiolabeled substrate, cystine. Blockade of this antiporter induced production of reactive oxygen species (ROS) within 4 hours and induced cell death within 48 hours at concentrations exceeding 25 μM. Furthermore, cell death and ROS production were significantly reduced by co-treatment with N-acetylcysteine, suggesting that CPZ toxicity is associated with ROS-induced cell death. These data suggest that CPZ can modulate system x activity in vitro and this translates into antinociception in an in vivo model of CIBP where systemic administration of CPZ successfully delayed the onset and reversed CIBP-induced nociceptive behaviors resulting from intrafemoral MDA-MB-231 tumors.

摘要

胱氨酸/谷氨酸逆向转运体作为氧化还原稳态的主要调节因子,已被证实与多种癌症相关。这种转运体在侵袭性癌细胞中分泌的过量谷氨酸,与远端乳腺癌转移引起的癌症诱导性骨痛(CIBP)有关。通过高通量筛选乳腺癌细胞中谷氨酸释放的小分子抑制剂,鉴定出了几种潜在化合物。其中一种化合物,辣椒素(CPZ),通过其阻断放射性标记底物胱氨酸摄取的能力,被证实可抑制系统x(xCT)功能单位。在浓度超过25μM时,该逆向转运体的阻断在4小时内诱导活性氧(ROS)生成,并在48小时内诱导细胞死亡。此外,通过与N-乙酰半胱氨酸共同处理,细胞死亡和ROS生成显著减少,表明CPZ毒性与ROS诱导的细胞死亡有关。这些数据表明,CPZ可在体外调节系统x活性,这在CIBP体内模型中转化为镇痛作用,即全身给予CPZ成功延迟了由股内MDA-MB-231肿瘤引起的CIBP发作并逆转了其伤害性反应行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/da874b4a89d2/jpr-10-915Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/979f5b10eaa4/jpr-10-915Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/6e2f8d3f9afa/jpr-10-915Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/2a1f2e122014/jpr-10-915Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/054eb2fe7170/jpr-10-915Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/bd076bf0bbab/jpr-10-915Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/da874b4a89d2/jpr-10-915Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/979f5b10eaa4/jpr-10-915Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/6e2f8d3f9afa/jpr-10-915Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/2a1f2e122014/jpr-10-915Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/054eb2fe7170/jpr-10-915Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/bd076bf0bbab/jpr-10-915Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb1/5402992/da874b4a89d2/jpr-10-915Fig6.jpg

相似文献

1
Identification of capsazepine as a novel inhibitor of system x and cancer-induced bone pain.辣椒平作为系统x和癌症诱导骨痛新型抑制剂的鉴定。
J Pain Res. 2017 Apr 18;10:915-925. doi: 10.2147/JPR.S125045. eCollection 2017.
2
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.胱氨酸/谷氨酸逆向转运体系统xc-驱动乳腺肿瘤细胞释放谷氨酸并引发癌症诱导的骨痛。
Pain. 2016 Nov;157(11):2605-2616. doi: 10.1097/j.pain.0000000000000681.
3
xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.xCT 敲低可延缓乳腺癌细胞所致癌性骨痛的发生。
Mol Pain. 2019 Jan-Dec;15:1744806918822185. doi: 10.1177/1744806918822185.
4
Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception.在人乳腺癌骨痛模型中抑制 STAT3 可延迟痛觉敏化的发生。
Mol Pain. 2019 Jan-Dec;15:1744806918823477. doi: 10.1177/1744806918823477.
5
Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.信号转导子与转录激活子3和5调节人乳腺癌细胞中的系统Xc-及氧化还原平衡。
Mol Cell Biochem. 2015 Jul;405(1-2):205-21. doi: 10.1007/s11010-015-2412-4. Epub 2015 Apr 21.
6
Functional effects of TrkA inhibition on system x-mediated glutamate release and cancer-induced bone pain.TrkA 抑制对系统 x 介导的谷氨酸释放和癌性骨痛的功能影响。
Mol Pain. 2018 Jan-Dec;14:1744806918776467. doi: 10.1177/1744806918776467.
7
F-5-Fluoroaminosuberic Acid as a Potential Tracer to Gauge Oxidative Stress in Breast Cancer Models.F-5-氟氨基辛二酸作为评估乳腺癌模型氧化应激的潜在示踪剂。
J Nucl Med. 2017 Mar;58(3):367-373. doi: 10.2967/jnumed.116.180661. Epub 2016 Oct 27.
8
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.慢性抑制 STAT3/STAT5 对难治性人乳腺癌细胞亚型的作用:聚焦于 ROS/SUMO 途径及其对 xCT 表达和系统 xc- 活性的影响
PLoS One. 2016 Aug 11;11(8):e0161202. doi: 10.1371/journal.pone.0161202. eCollection 2016.
9
Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain.用柳氮磺胺吡啶抑制乳腺癌细胞谷氨酸释放可减轻癌症引起的骨痛。
Pain. 2014 Jan;155(1):28-36. doi: 10.1016/j.pain.2013.08.030. Epub 2013 Aug 30.
10
Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain.乳腺癌细胞谷氨酸释放抑制剂;癌症诱导骨痛的新靶点。
Sci Rep. 2015 Feb 11;5:8380. doi: 10.1038/srep08380.

引用本文的文献

1
SLC7A11 Inhibitors Represent a Promising Therapeutic Target by Facilitating the Induction of Ferroptosis in Breast Cancer.SLC7A11抑制剂通过促进乳腺癌中铁死亡的诱导而成为一个有前景的治疗靶点。
Int J Mol Cell Med. 2025;14(1):496-516. doi: 10.22088/IJMCM.BUMS.14.1.496.
2
Role of TRP Channels in Cancer-Induced Bone Pain.瞬时受体电位通道在癌性骨痛中的作用。
Int J Mol Sci. 2025 Jan 30;26(3):1229. doi: 10.3390/ijms26031229.
3
Natural and Synthetic Capsaicin Analogues: A Comprehensive Review of Biological Effects and Synthetic Pathways.

本文引用的文献

1
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.胱氨酸/谷氨酸逆向转运体系统xc-驱动乳腺肿瘤细胞释放谷氨酸并引发癌症诱导的骨痛。
Pain. 2016 Nov;157(11):2605-2616. doi: 10.1097/j.pain.0000000000000681.
2
Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain.骨癌痛模型中骨骼疼痛行为缓解与皮肤超敏反应之间的分离
Pain. 2016 Jun;157(6):1239-1247. doi: 10.1097/j.pain.0000000000000514.
3
Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain.
天然与合成辣椒素类似物:生物学效应与合成途径的全面综述
Curr Med Chem. 2025;32(24):4963-4991. doi: 10.2174/0109298673310050240821054652.
4
Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches.探索氨基酸转运体作为癌症治疗靶点:抑制剂结构、选择性问题及发现方法研究
Pharmaceutics. 2024 Jan 30;16(2):197. doi: 10.3390/pharmaceutics16020197.
5
Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications.癌症诱导性骨痛中的离子通道:从分子机制到临床应用
Front Mol Neurosci. 2023 Aug 17;16:1239599. doi: 10.3389/fnmol.2023.1239599. eCollection 2023.
6
Anticancer Activity of Region B Capsaicin Analogs.区域 B 辣椒素类似物的抗癌活性。
J Med Chem. 2023 Apr 13;66(7):4294-4323. doi: 10.1021/acs.jmedchem.2c01594. Epub 2023 Mar 31.
7
Ferroptosis-modulating small molecules for targeting drug-resistant cancer: Challenges and opportunities in manipulating redox signaling.调控铁死亡的小分子靶向耐药性癌症药物:调控氧化还原信号的挑战与机遇。
Med Res Rev. 2023 May;43(3):614-682. doi: 10.1002/med.21933. Epub 2023 Jan 19.
8
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.胱氨酸/谷氨酸反向转运体SLC7A11/xCT在癌症病理生理学中的作用
Front Oncol. 2022 Feb 23;12:858462. doi: 10.3389/fonc.2022.858462. eCollection 2022.
9
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies.肿瘤相关抗原 xCT 和突变型 p53 作为新的抗肿瘤联合策略的分子靶点。
Cells. 2021 Jan 8;10(1):108. doi: 10.3390/cells10010108.
10
SLC7A11/xCT in cancer: biological functions and therapeutic implications.癌症中的溶质载体家族7成员11/胱氨酸-谷氨酸反向转运体:生物学功能及治疗意义
Am J Cancer Res. 2020 Oct 1;10(10):3106-3126. eCollection 2020.
乳腺癌细胞谷氨酸释放抑制剂;癌症诱导骨痛的新靶点。
Sci Rep. 2015 Feb 11;5:8380. doi: 10.1038/srep08380.
4
The neurobiology of cancer pain.癌症疼痛的神经生物学
Neuroscientist. 2014 Oct;20(5):546-62. doi: 10.1177/1073858414525828. Epub 2014 Mar 24.
5
Recent advances in cancer pain management.癌症疼痛管理的最新进展。
F1000Prime Rep. 2014 Feb 3;6:10. doi: 10.12703/P6-10. eCollection 2014.
6
Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.代谢型谷氨酸受体 1 促进三阴性乳腺癌的进展。
PLoS One. 2014 Jan 3;9(1):e81126. doi: 10.1371/journal.pone.0081126. eCollection 2014.
7
Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin.实验性骨转移导致的溶骨性破坏和疼痛可通过雷帕霉素治疗得到改善。
Breast Cancer Res Treat. 2014 Jan;143(2):227-37. doi: 10.1007/s10549-013-2799-0. Epub 2013 Dec 11.
8
TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception.TRPV1 拮抗剂与慢性疼痛:超越热感知。
Pharmaceuticals (Basel). 2012 Feb 2;5(2):114-32. doi: 10.3390/ph5020114.
9
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.谷氨酰胺敏感性分析确定 xCT 外排体为常见的三阴性乳腺癌治疗靶点。
Cancer Cell. 2013 Oct 14;24(4):450-65. doi: 10.1016/j.ccr.2013.08.020. Epub 2013 Oct 3.
10
Cancer-induced bone pain: Mechanisms and models.癌症相关性骨痛:机制与模型。
Neurosci Lett. 2013 Dec 17;557 Pt A(0 0):52-9. doi: 10.1016/j.neulet.2013.08.003. Epub 2013 Sep 25.